REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis

Ratziu V, Sanyal AJ, Loomba R, Rinella M, Harrison S, Anstee QM, Goodman Z, Bedossa P, MacConell L, Shringarpure R, Shah A, Younossi Z.
Contemp Clin Trials. 2019 Jun 29;84:105803. doi: 10.1016/j.cct.2019.06.017.

in cat NOT

Stay Connected

Would you like to receive updates from ProSciento?